DrugRisk Reports Mirena Lawsuits May Be Headed to Federal Court
The DrugRisk Resource Center is the Web´s largest source for information on medical device research, side effects and legal news. Visit http://www.DrugRisk.com
New York, NY (PRWEB) January 23, 2013
DrugRisk.com, the premiere resource center for prescription drug warnings, recalls, studies and litigation news, is alerting patients using the IUD contraceptive Mirena of new information on the site showing victims have asked that all federal lawsuits be moved to a central court.
“The goal of DrugRisk is to improve patient safety through education. By providing the public with the latest information, patients can have informed discussions with their doctors about drug side effects and decide if they need to seek the advice of a lawyer,” explains DrugRisk representative Ryan Mayer.
Information on the resource center shows that the FDA warned Bayer, the maker of Mirena, about the marketing of the device in 2009, after they failed to disclose safety risks while claiming the devices could help busy moms with intimacy and make them “look and feel great.”*
DrugRisk has also learned that the FDA has received over 45,000 AERS reports of women suffering complications while using the Mirena IUD. Of these, 5079 involved dislocation and 1421 involved migration of the devices, which can perforate or damage the uterine wall.** In more than 6% of cases, patients required hospitalization or surgery.
With growing litigation over device perforation, Bayer had asked the New Jersey Superior Court to consolidate Mirena lawsuits to a court closer to its U.S. headquarters in Middlesex County, New Jersey. However, the court denied this request on January 8, 2013.***
Now, DrugRisk reports that plaintiffs filed a petition on January 16th requesting cases be consolidated in a special federal Multi-District Litigation court in Ohio.**** The petition estimates that, with more than 2 million Mirena users, hundreds of perforation cases may be filed.
Anyone affected by a Mirena device is urged to learn about their legal rights to file a claim. Due to the specialized nature of federal MDL drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Mirena lawsuits. At this point there has been no Mirena recall, but patients are urged to speak with their doctor if complications arise.
For more information on the research, side effects and litigation news related to Mirena and other medical devices, or to speak with a lawyer, visit http://www.DrugRisk.com.
*NDA 21-225, Mirena (levonorgestrel-releasing intrauterine system) MACMIS # 18166, 12/30/09
**FDA AERS Reports for Mirena through June 30, 2012 – drugcite.com/?q=mirena
****In Re: Mirena IUD Product Liability Litigation, Case No. 1:12-CV-2780; harrismartin.com/media/uploads/documents/DRU-1301-27.pdf
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebmirena-recall/warnings-lawsuit/prweb10349328.htm